Immune Checkpoint Inhibitors
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Plinabulin | BeyondSpring Inc. (BYSI) |
Phase 1(1)
| Drug | Company |
|---|---|
| PLN-101095 | PLIANT THERAPEUTICS, INC. (PLRX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Immune Checkpoint Inhibitors?
BioSniper tracks 2 drugs in development for Immune Checkpoint Inhibitors across 2 companies.
How many clinical trials target Immune Checkpoint Inhibitors?
There are 1 clinical trial targeting Immune Checkpoint Inhibitors tracked by BioSniper.
Deep-dive into Immune Checkpoint Inhibitors
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis